Role of metabolism and receptor responsiveness in the attenuated responses to Angiotensin II in mice compared to rats

Regulatory Peptides

Volumn 117, Issue 2, 2004, Pages 107-116

  Cassis, Lisa A ^a,b   Huang, Jing ^b   Gong, Ming C ^c   Daugherty, Alan ^b,c  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Angiotensin; Blood pressure; Differences between rats and mice

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR;

ANIMAL MODEL; AORTA STRIP; ARTICLE; ATTENUATION; BINDING AFFINITY; BLOOD LEVEL; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CATABOLISM; CONTROLLED STUDY; DENSITY; DRUG INFUSION; HISTOLOGY; HYPERTROPHY; KIDNEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT; REDUCTION; REGULATORY MECHANISM; RODENT; SPLEEN;

RODENTIA;

EID: 0346099207     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2003.09.008     Document Type: Article

References (43)

1. Peach M.J. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol. Rev. 57:1977;313-370.
2. Simon G., Cserep G., Limas C. Development of structural vascular changes with subpressor angiotensin II administration in rats. Am. J. Hypertens. 1995;67-73.
3. Li Q., Dale W.E., Hasser E.M., Blaine E.H. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency. Am. J. Physiol. 271:1996;R200-R207.
4. Simon G., Abraham G., Cserep G. Pressor and subpressor angiotensin II administration. Two experimental models of hypertension. Am. J. Hypertens. 8:1995;645-650.
5. Su E.J., Lombardi D.M., Siegal J., Schwartz S.M. Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure. Hypertension. 31:1998;1331-1337.
6. Cassis L., Helton M., English V., Burke G. Angiotensin II regulates oxygen consumption. Am. J. Physiol., Regul. Integr. Comp. Physiol. 282:2002;R445-R453.
7. Sun Y., Ramires F.J., Zhou G., Ganjam V.K., Weber K.T. Fibrous tissue and angiotensin II. J. Mol. Cell. Cardiol. 29:1997;2001-2012.
8. Brink M., Wellen J., Delafontaine P. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J. Clin. Invest. 97:1996;2509-2516.
9. Cassis L.A., Marshall D.E., Fettinger M.J., Rosenbluth B., Lodder R.A. Mechanisms contributing to angiotensin II regulation of body weight. Am. J. Physiol. 274:1998;E867-E876.
10. English V., Cassis L. Facilitation of sympathetic neurotransmission contributes to angiotensin regulation of body weight. J. Neural Transm. 106:1999;631-644.
11. Kim H.S., Krege J.H., Kluckman K.D., Hagaman J.R., Hodgin J.B., Best C.F., Jennette J.C., Coffman T.M., Maeda N., Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. U. S. A. 92:1995;2729-2735.
12. Yanai K., Saito T., Kakinuma Y., Kon Y., Hirota K., Taniguchi-Yanai K., Nishijo N., Shigematsu Y., Horiguchi H., Kasuya Y., Sugiyama F., Yagami K., Murakami K., Fukamizu A. Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice. J Biol Chem. 275:2000;5-8.
13. Oliverio M.I., Best C.F., Kim H.S., Arendshorst W.J., Smithies O., Coffman T.M. Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation. Am. J. Physiol. 272:1997;F515-F520.
14. Oliverio M.I., Madsen K., Best C.F., Ito M., Maeda N., Smithies O., Coffman T.M. Renal growth and development in mice lacking AT1A receptors for angiotensin II. Am. J. Physiol. 274:1998;F43-50.
15. Hein L., Barsh G.S., Pratt R.E., Dzau V.J., Kobilka B.K. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature. 377:1995;744-747.
16. Siragy H.M., Carey R.M. Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension. 33:1999;1237-1242.
17. Daugherty A., Cassis L.A. Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor-/- mice. Proc. N.Y. Acad. Sci. 892:1999;108-118.
18. Daugherty A., Manning M.W., Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105:2000;1605-1612.
19. Daugherty A., Manning M.W., Cassis L.A. Antagonism of AT2 receptors augments Angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br. J. Pharmacol. 134:2001;865-870.
20. Roselaar S.E., Kakkanathu P.X., Daugherty A. Lymphocyte populations in atherosclerotic lesions of apoE-/- and LDL receptor-/- mice. Decreasing density with disease progression. Arterioscler. Thromb. Vasc. Biol. 16:1996;1013-1018.
21. Gong M.C., Fuglsang A., Alessi D., Kobayashi S., Cohen P., Somlyo A.V., Somlyo A.P. Arachidonic acid inhibits myosin light chain phosphatase and sensitizes smooth muscle to calcium. J. Biol. Chem. 267:1992;21492-21498.
22. Bendall J.K., Cave A.C., Heymes C., Gall N., Shah A.M. Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation. 105:2002;293-296.
23. Manning M.W., Cassis L.A., Daugherty A. Differential effects of doxycycline, a broad spectrum MMP inhibitor, on AngII-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 2003;. [In press].
24. Shi S.J., Nguyen H.T., Sharma G.D., Navar L.G., Pandey K.N. Genetic disruption of atrial natriuretic peptide receptor-A alters renin and angiotensin II levels. Am. J. Physiol., Renal Physiol. 281:2001;F665-F673.
25. Cholewa B.C., Mattson D.L. Role of the renin-angiotensin system during alterations of sodium intake in conscious mice. Am. J. Physiol., Regul. Integr. Comp. Physiol. 281:2001;R987-R993.
26. van Kats J.P., Methot D., Paradis P., Silversides D.W., Reudelhuber T.L. Use of a biological peptide pump to study chronic peptide hormone action in transgenic mice. Direct and indirect effects of angiotensin II on the heart. J. Biol. Chem. 276:2001;44012-44017.
27. Cole J., Quach du L., Sundaram K., Corvol P., Capecchi M.R., Bernstein K.E. Mice lacking endothelial Angiotensin-converting enzyme have a normal blood pressure. Circ. Res. 90:2002;87-92.
28. Sakura H., Kobayashi H., Mizutani S., Sakura N., Hashimoto T., Kawashima Y. Kinetic properties of placental aminopeptidase A: N-terminal degradation of angiotensin II. Biochem. Int. 6:1983;609-615.
29. Ahmad S., Ward P.E. Role of aminopeptidase activity in the regulation of the pressor activity of circulating angiotensins. J. Pharmacol. Exp. Ther. 252:1990;643-650.
30. Abhold R.H., Harding J.W. Metabolism of angiotensins II and III by membrane-bound peptidases from rat brain. J. Pharmacol. Exp. Ther. 245:1988;171-177.
31. Wright J.W., Harding J.W. Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions. Regul. Pept. 59:1995;269-295.
32. Albiston A.L., McDowall S.G., Matsacos D., Sim P., Clune E., Mustafa T., Lee J., Mendelsohn F.A., Simpson R.J., Connolly L.M., Chai S.Y. Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J. Biol. Chem. 276:2001;48623-48626.
33. Cesari M., Rossi G.P., Pessina A.C. Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseases. J. Hypertens. 20:2002;793-799.
34. Harding J.W., Wright J.W., Swanson G.N., Hanesworth J.M., Krebs L.T. AT4 receptors: specificity and distribution. Kidney Int. 46:1994;1510-1512.
35. Patel J.M., Martens J.R., Li Y.D., Gelband C.H., Raizada M.K., Block E.R. Angiotensin IV receptor-mediated activation of lung endothelial NOS is associated with vasorelaxation. Am. J. Physiol. 275:1998;L1061-L1068.
36. de Oliveira A.M., Viswanathan M., Heemskerk F.M., Correa F.M., Saavedra J.M. Specific, non-angiotensin,[125I]CGP 42112 binding sites in rat spleen macrophages. Biochem. Biophys. Res. Commun. 200:1994;1049-1058.
37. Tsutsumi K., Stromberg C., Saavedra J.M. Characterization of angiotensin II receptor subtypes in the rat spleen. Peptides. 13:1992;291-296.
38. Harrison-Bernard L.M., El-Dahr S.S., O'Leary D.F., Navar L.G. Regulation of angiotensin II type 1 receptor mRNA and protein in angiotensin II-induced hypertension. Hypertension. 33:1999;340-346.
39. Cao Z., Dean R., Wu L., Casley D., Cooper M.E. Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy. Hypertension. 34:1999;408-414.
40. Wang D.H., Du Y., Yao A. Regulation of the gene-encoding angiotensin II receptor in vascular tissue. Microcirculation. 3:1996;237-239.
41. Wang D.H., Du Y., Yao A., Hu Z. Regulation of type 1 angiotensin II receptor and its subtype gene expression in kidney by sodium loading and angiotensin II infusion. J. Hypertens. 14:1996;1409-1415.
42. Tanaka M., Tsuchida S., Imai T., Fujii N., Miyazaki H., Ichiki T., Naruse M., Inagami T. Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice. Biochem. Biophys. Res. Commun. 258:1999;194-198.
43. Russell A., Watts S. Vascular reactivity of isolated thoracic aorta of the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 294:2000;598-604.